Arkolith/Insider Trading/NARI/Form 4

Strange Kevin T

Chief Financial OfficerInari Medical, Inc. (NARI) · full profile →Form 4 · filed Oct 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
7 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 1, 2024Tax withholding(F)54$40.63$2K48K
Oct 1, 2024Tax withholding(F)240$40.63$10K47K
Oct 1, 2024Tax withholding(F)198$40.63$8K48K
Oct 1, 2024Tax withholding(F)152$40.63$6K48K
Oct 1, 2024Tax withholding(F)129$40.63$5K48K
Oct 1, 2024Grant(A)6K—$048K
Oct 1, 2024Tax withholding(F)268$40.63$11K48K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-24-025141) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML